The application of artificial intelligence to help discover new medicines could become one of the more transformative ways we use this tech in the near term. Recursion Pharmaceuticals CEO Chris Gibson takes us on a tour of the world's largest phenomics lab. We Meet: Recursion Co-Founder & CEO Chris Gibson Credits: This episode of SHIFT was produced by Jennifer Strong with help from Emma Cillekens. It was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.
